Samuel Wrenn

2.8k total citations
3 papers, 180 citations indexed

About

Samuel Wrenn is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Samuel Wrenn has authored 3 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 1 paper in Molecular Biology and 1 paper in Neurology. Recurrent topics in Samuel Wrenn's work include SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Angiogenesis and VEGF in Cancer (1 paper). Samuel Wrenn is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Angiogenesis and VEGF in Cancer (1 paper). Samuel Wrenn collaborates with scholars based in United States. Samuel Wrenn's co-authors include Neil P. King, Helen Y. Chu, Kiel Shuey, Katharine H. D. Crawford, Rachel Eguia, Brooke Fiala, Amanda M. Casto, Caitlin R. Wolf, Deleah Pettie and Alexander L. Greninger and has published in prestigious journals such as The Journal of Infectious Diseases, EMBO Reports and Journal of Immunological Methods.

In The Last Decade

Samuel Wrenn

3 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samuel Wrenn United States	3	165	29	27	23	12	3	180
Preshetha Kanagaiah United States	2	133 0.8×	21 0.7×	18 0.7×	21 0.9×	19 1.6×	2	141
Becky Batchelor United Kingdom	4	174 1.1×	24 0.8×	10 0.4×	24 1.0×	12 1.0×	5	189
Maria Squires United Kingdom	3	169 1.0×	23 0.8×	9 0.3×	24 1.0×	13 1.1×	4	182
Mazuba Siamatu United States	3	146 0.9×	15 0.5×	23 0.9×	31 1.3×	23 1.9×	3	166
Emily Degli-Angeli United States	4	145 0.9×	15 0.5×	31 1.1×	9 0.4×	16 1.3×	4	154
Sarah Ducat United States	3	128 0.8×	13 0.4×	18 0.7×	29 1.3×	15 1.3×	3	148
Sai Priya Anand Canada	4	126 0.8×	14 0.5×	15 0.6×	21 0.9×	13 1.1×	5	134
Karl CK Chan Hong Kong	3	254 1.5×	17 0.6×	22 0.8×	19 0.8×	8 0.7×	3	269
Kiel Shuey United States	4	166 1.0×	29 1.0×	15 0.6×	24 1.0×	21 1.8×	6	208
Kristina Reppond United States	3	141 0.9×	19 0.7×	27 1.0×	28 1.2×	8 0.7×	3	165

Countries citing papers authored by Samuel Wrenn

Since Specialization

Citations

This map shows the geographic impact of Samuel Wrenn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Wrenn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Wrenn more than expected).

Fields of papers citing papers by Samuel Wrenn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Wrenn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Wrenn. The network helps show where Samuel Wrenn may publish in the future.

Co-authorship network of co-authors of Samuel Wrenn

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Wrenn. A scholar is included among the top collaborators of Samuel Wrenn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Wrenn. Samuel Wrenn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Zhao, Yan Ting, Jorge A. Fallas, Shally Saini, et al.. (2021). F‐domain valency determines outcome of signaling through the angiopoietin pathway. EMBO Reports. 22(12). e53471–e53471. 12 indexed citations

2.

Larsen, Sasha E., Bryan J. Berube, Bryan P. Brown, et al.. (2021). Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples. Journal of Immunological Methods. 499. 113160–113160. 16 indexed citations

3.

Crawford, Katharine H. D., Adam S. Dingens, Rachel Eguia, et al.. (2020). Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. The Journal of Infectious Diseases. 223(2). 197–205. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact